Jackson Square Partners LLC Sells 390,436 Shares of STAAR Surgical (NASDAQ:STAA)

Jackson Square Partners LLC lowered its position in STAAR Surgical (NASDAQ:STAA - Free Report) by 18.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,694,992 shares of the medical instruments supplier's stock after selling 390,436 shares during the quarter. STAAR Surgical accounts for approximately 1.7% of Jackson Square Partners LLC's holdings, making the stock its 27th biggest holding. Jackson Square Partners LLC owned about 3.47% of STAAR Surgical worth $52,901,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in STAA. Clear Street Markets LLC bought a new stake in shares of STAAR Surgical in the 3rd quarter worth about $29,000. Nisa Investment Advisors LLC grew its position in shares of STAAR Surgical by 415.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,445 shares of the medical instruments supplier's stock valued at $98,000 after buying an additional 1,971 shares during the last quarter. Covestor Ltd grew its position in shares of STAAR Surgical by 82,466.7% during the 3rd quarter. Covestor Ltd now owns 2,477 shares of the medical instruments supplier's stock valued at $100,000 after buying an additional 2,474 shares during the last quarter. Van ECK Associates Corp grew its position in shares of STAAR Surgical by 44.5% during the 3rd quarter. Van ECK Associates Corp now owns 3,184 shares of the medical instruments supplier's stock valued at $128,000 after buying an additional 980 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of STAAR Surgical by 171.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 3,755 shares of the medical instruments supplier's stock valued at $151,000 after buying an additional 2,372 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company's stock.

Insider Buying and Selling at STAAR Surgical

In related news, Director Aimee S. Weisner acquired 1,750 shares of the company's stock in a transaction on Thursday, March 14th. The shares were purchased at an average price of $38.11 per share, for a total transaction of $66,692.50. Following the purchase, the director now owns 10,864 shares in the company, valued at $414,027.04. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of STAAR Surgical in a research report on Wednesday, May 8th. William Blair upgraded shares of STAAR Surgical from a "market perform" rating to an "outperform" rating in a research report on Thursday, April 4th. Stifel Nicolaus restated a "buy" rating and issued a $50.00 target price on shares of STAAR Surgical in a research report on Monday, April 1st. Mizuho upped their target price on shares of STAAR Surgical from $53.00 to $55.00 and gave the stock a "buy" rating in a research report on Wednesday, May 8th. Finally, Canaccord Genuity Group decreased their target price on shares of STAAR Surgical from $46.00 to $43.00 and set a "hold" rating for the company in a research report on Wednesday, May 8th. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $47.13.

STAAR Surgical Trading Up 0.2 %

STAA stock traded up $0.08 on Friday, hitting $42.70. 333,177 shares of the company's stock traded hands, compared to its average volume of 523,920. STAAR Surgical has a 1-year low of $26.66 and a 1-year high of $65.07. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 137.74 and a beta of 0.80. The stock has a fifty day moving average of $43.37 and a 200-day moving average of $36.00.

STAAR Surgical (NASDAQ:STAA - Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.12). The firm had revenue of $77.40 million during the quarter, compared to analysts' expectations of $75.34 million. STAAR Surgical had a net margin of 4.69% and a return on equity of 6.83%. The firm's revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.05 EPS. On average, equities research analysts anticipate that STAAR Surgical will post 0.08 earnings per share for the current fiscal year.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.